Also on Trial Friend:Arrhythmogenic Cardiomyopathy pageMatch Me
All 20 Arrhythmogenic Cardiomyopathy trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)Most sites in California, Colorado and MarylandRecruitingAges 14-65Tenaya Therapeutics8US sites
8 states - Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCMost sites in California, Colorado and MarylandRecruitingPhase 1Ages 18-65Tenaya Therapeutics7US sites
7 states - A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACMMost sites in Maryland, Michigan and CaliforniaRecruitingAges 18-65Lexeo Therapeutics6US sites
4 states - A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)Most sites in California and North CarolinaRecruitingPhase 1Ages 18+Rocket Pharmaceuticals2US sites
2 states - Cardiovascular Multimodality Imaging StudyOnly in New YorkRecruitingAges 18+Montefiore Medical Center1US site
- Mayo AVC Registry and BiobankOnly in MinnesotaRecruitingMayo Clinic1US site
- Pediatric Cardiomyopathy Mutation AnalysisOnly in IndianaRecruitingIndiana University1US site
- Arrhythmogenic Activity During Exercise in ARVC PatientsRecruitingAges 14+Swiss Federal Institute of TechnologyNo US site yet
- Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis TransitionRecruitingAges 30-90University of EdinburghNo US site yet
- Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac TransplantationRecruitingAges 12+IRCCS Azienda Ospedaliero-Universitaria di BolognaNo US site yet
- DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research StudiesRecruitingAges 18-80University Hospital HeidelbergNo US site yet
- FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC))RecruitingAges 18+Istanbul University - CerrahpasaNo US site yet
- Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic CardiomyopathyRecruitingAges 18+Centro Medico TeknonNo US site yet
- Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.RecruitingAges 18+Scientific Institute San RaffaeleNo US site yet
- Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic CardiomyopathyRecruitingAges 18+First Affiliated Hospital Xi'an Jiaotong UniversityNo US site yet
- Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)RecruitingPhase 2Ages 18+Centro Cardiologico MonzinoNo US site yet
- Subcutaneous Implantable Cardioverter-defibrillator (S-ICD) Eligibility Over Time in Arrhythmogenic CardiomyopathyRecruitingAges 18+University of Sao PauloNo US site yet
- Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic CardiomyopathyRecruitingPhase 2Ages 18+Hamilton Health SciencesNo US site yet
- The Application of T1 Mapping in Real-WorldRecruitingChinese Academy of Medical Sciences, Fuwai HospitalNo US site yet
- Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of CardiomyopathyRecruitingAges 16-99Nantes University HospitalNo US site yet
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Arrhythmogenic Cardiomyopathy trials in the US, and what stage they are in
None of the 7 Arrhythmogenic Cardiomyopathy trials with a US site is in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 2 of them. The remaining 5 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 4 of them, and universities, hospitals, foundations and government groups run 3. Tenaya Therapeutics runs the most, with 2. The most recently listed one first appeared on ClinicalTrials.gov on May 16, 2025.
Arrhythmogenic Cardiomyopathy trials in the US, state by state
Of the 7 Arrhythmogenic Cardiomyopathy trials with a US site, 3 accept children under 18. Their open sites are in 9 states, most often Minnesota, California and Colorado. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 1 state
US hospitals running the most Arrhythmogenic Cardiomyopathy trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Arrhythmogenic Cardiomyopathy.
- Mayo ClinicRochester, Minnesota3 trials
- Brigham and Women's HospitalBoston, Massachusetts2 trials
- Cleveland ClinicCleveland, Ohio2 trials
- Johns Hopkins UniversityBaltimore, Maryland2 trials
- University of California San FranciscoSan Francisco, California2 trials
- Duke UniversityDurham, North Carolina1 trial
- Henry Ford HospitalDetroit, Michigan1 trial
- IU School of MedicineIndianapolis, Indiana1 trial
- John Hopkins University School of MedicineBaltimore, Maryland1 trial
- Leland Stanford Junior UniversityRedwood City, California1 trial
Help getting to an Arrhythmogenic Cardiomyopathy trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding an Arrhythmogenic Cardiomyopathy trial near you
Are there Arrhythmogenic Cardiomyopathy clinical trials near me?
As of November 13, 2026, 20 Arrhythmogenic Cardiomyopathy clinical trials are recruiting now and 4 are not yet recruiting. In the US, 7 of them have at least 1 open site, across 11 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Arrhythmogenic Cardiomyopathy clinical trial sites?
Recruiting Arrhythmogenic Cardiomyopathy trials list open sites in California, Colorado, Indiana, Maryland, Massachusetts, Michigan, Minnesota, New York, North Carolina, Ohio and South Carolina.
Are there Arrhythmogenic Cardiomyopathy trials for children near me?
Of the 7 Arrhythmogenic Cardiomyopathy trials with a US site, 3 accept children under 18. Their open sites are in 9 states, most often Minnesota, California and Colorado. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to an Arrhythmogenic Cardiomyopathy clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.
What if there is no Arrhythmogenic Cardiomyopathy trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when an Arrhythmogenic Cardiomyopathy trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.
